207_Combined course Presentations

Hybrid study: SBRT with concurrent chemoradiation

Toxicity profile using CTCAE v4

DVH parameters

Conclusions

 A Hybrid treatment of SBRT of the primary tumor combined with fractionated radiotherapy on the lymph nodes with concurrent chemotherapy is feasible.

 This phase I trial (NCT01933568) is currently accruing and no unexpected toxicity has been observed thus far.

Courtesy of J. Belderbos